Danger Signs in Heart Failure- Effects of Video Education

NCT ID: NCT03657459

Last Updated: 2025-05-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

746 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-26

Study Completion Date

2022-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lack of recognition of HF danger signs and lack of understanding of how to control and minimize danger signs could lead to their escalation and prompt all-cause and HF-related health care resource utilization (HCRU). Investigators hypothesize that patients must understand HF danger signs to have self-confidence in recognizing them and in taking steps to minimize or eliminate their occurrence post hospital discharge. Investigators will determine if video education in HF danger signs recognition and control prior to discharge (and post-discharge) reduces all-cause and HF-related HCRU.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The most frequently cited danger signs of heart failure (HF) are new onset or worsening of fatigue, dyspnea and edema. In previous research, patients did not recognize worsening HF, due to 3 primary reasons: (1) danger signs were non-specific and misinterpreted as stress, an external force or another comorbidity, (2) danger signs were unrecognized due to the subtle nature of worsening status, or (3) when patients eliminated or minimized activities that prompted danger signs, they interpreted the results as improvement in status. Lack of recognition of HF danger signs and lack of understanding of how to control and minimize danger signs could lead to their escalation and prompt all-cause and HF-related health care resource utilization (HCRU). Investigators hypothesize that patients must understand HF danger signs to have self-confidence in recognizing them and in taking steps to minimize or eliminate their occurrence post hospital discharge. The purposes of this trial are to determine if video education in HF danger signs recognition and control prior to discharge (and post-discharge) reduces all-cause and HF-related health care resource utilization. The intervention will be administered during hospitalization, and patients and family members will receive a link to a website and a DVD to review videos as often as desired post-discharge. The primary end-point is 30-day HF-related hospitalization. 732 patients (658 + 10% attrition) with decompensated HF will be enrolled from multiple hospitals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure; With Decompensation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, controlled prospective trial
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Investigators
Documentation of enrollment will not include group assignment Investigator will be blinded from group assignment via a separate excel file with that detail

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

usual care group

Usual care consists of patient's receiving a Heart Failure Handbook before hospital discharge + verbal education delivered by multiple care providers (including a group education class at 1 site). The handbook is consistent; however, verbal education may vary between care providers based on their knowledge and time available, and perceived patient needs

Group Type NO_INTERVENTION

No interventions assigned to this group

video education group

Will receive usual care, plus will watch 2 short Wellflix, Inc. Danger Signs of Heart Failure videos (via iPAD) on dyspnea, fatigue + a Danger Sign "edema" video, when applicable. Each video describes how to recognize if the sign/symptom is new or worsening and how to self-manage at home (via diet, fluid management and activity instructions)

Group Type ACTIVE_COMPARATOR

Danger Signs of Heart Failure Videos

Intervention Type BEHAVIORAL

Short (under 3 minutes each) videos on (a) recognition of dyspnea, fatigue and edema and (b) self-management of each (based on diet, fluid management and activities) that reflect patient behaviors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Danger Signs of Heart Failure Videos

Short (under 3 minutes each) videos on (a) recognition of dyspnea, fatigue and edema and (b) self-management of each (based on diet, fluid management and activities) that reflect patient behaviors

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Not referred for cardiac transplantation or ventricular assist device placement during the index hospitalization,
* Cognitively intact and able to view videos (adequate eyesight and hearing) with correction, if needed,
* Discharge to home, assisted living facility or to a family member's home and can control dietary sodium and fluids as needed,
* Willing to participate; which may require up to three (3) follow-up telephone calls post-discharge.

Exclusion Criteria

* Chart documented psychiatric or cognitive conditions that limit ability to understand video content or adhere to self-care recommendations (Alzheimer's condition, dementia, schizophrenia, other neurological history that impairs memory or concentration),
* Plans to discharge to skilled nursing facility or hospice care,
* Receiving home hospice or palliative care; or has a medical condition reflecting less than 1 year of survival (cachexia, end stage liver disease or cancer or non-ambulatory New York Heart Association functional class IV HF),
* Hospitalized but at admission, in New York Heart Association functional class I or II HF
* Post-cardiac transplantation or ventricular assist device placement,
* Currently enrolled in another experimental HF research study,
* Chronic renal failure and receiving chronic hemodialysis therapy for an estimated glomerular filtration rate \< 15 mL/minute/1.73 m2,
* A non-traditional form of HF (hypertrophic or restrictive forms of cardiomyopathy, congenital heart disease or Takotsubo cardiomyopathy).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wellflix, Inc.

UNKNOWN

Sponsor Role collaborator

The Cleveland Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nancy M. Albert, Ph.D.

Assocaite Chief Nursing Officer-Resaerch and Senior Nurse Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

NANCY M. ALBERT, PhD

Role: PRINCIPAL_INVESTIGATOR

The Cleveland Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Center Navicent Health

Macon, Georgia, United States

Site Status

Cleveland Clinic Fairview Hospital

Cleveland, Ohio, United States

Site Status

Cleveland Clinic main campus

Cleveland, Ohio, United States

Site Status

Cleveland Clinic Marymount Hospital

Garfield Heights, Ohio, United States

Site Status

Cleveland Clinic Hillcrest Hospital

Mayfield Heights, Ohio, United States

Site Status

Cleveland Clinic Medina Hospital

Medina, Ohio, United States

Site Status

Cleveland Clinic South Pointe Hospital

Warrensville Heights, Ohio, United States

Site Status

WellSpan Health

York, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-442

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heart Failure Medication Adherence
NCT03402750 COMPLETED NA
Enhancing Heart Failure Self-Care
NCT00526773 COMPLETED NA
Biomarker Study: Heart Failure Patients at Risk
NCT05336175 UNKNOWN PHASE1/PHASE2